USPTO serial 79273882
CONNECT COLLABORATE ACCELERATE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 24, 2020
- Examiner
- MEYERS, MORGAN LAURA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CONNECT COLLABORATE ACCELERATE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BioPhorum Operations Group Limited
Sheffield, GB
Other trademarks owned by BioPhorum Operations Group Limited
BioPhorum Operations Group Limited
Sheffield, GB
Other trademarks owned by BioPhorum Operations Group Limited
BioPhorum Operations Group Limited
Sheffield, GB
Other trademarks owned by BioPhorum Operations Group Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angela P. Doughty
Angela P. Doughty Ward and Smith, P.A.751 Corporate Center Drive, Suite 300Post Office Box 33009Raleigh, NC 27636-3009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Compiling data for research purpose in the field of medical science and medical consultancy; product development consultation; pharmaceutical research and development; consultancy on pharmaceutical product development, biopharmaceutical product development, biotechnology product development, medical device product development; technical research in the field of pharmaceutical studies; technical research in the field of biopharmaceuticals, biotechnology, medical devices and life science studies; technical consulting in the field of pharmaceutical studies; consultancy in the field of pharmaceutical research; testing, inspection, research, or development of pharmaceutical preparations; research on the subject of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; providing medical and scientific research information in the field of biopharmaceuticals, biotechnology, medical devices and life sciences; Developing quality control standards for pharmaceutical, biopharmaceutical and medical device manufacturing; Consultancy services in relation to developing quality control standards for pharmaceutical, biopharmaceutical and medical device manufacturing; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of for pharmaceuticals, biopharmaceuticals, biotechnology, and medical devices; Consultancy services in relation to quality evaluation and analysis, quality assurance, and quality control, in the field of for pharmaceuticals, biopharmaceuticals, biotechnology, and medical devices; Advisory in the field of quality control of manufactured goods; scientific research in the field of healthcare, medical technology, medical devices, life sciences, pharmaceutical, biopharmaceutical, and biotechnology; providing consultation in the field of science, healthcare, medical technology, medical devices, life sciences, pharmaceutical, biopharmaceutical, and biotechnology; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare, pharmaceuticals, biopharmaceuticals, and medical devices | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioPhorum Operations Group Limited
- Other trademarks owned by BioPhorum Operations Group Limited
- Other trademarks owned by BioPhorum Operations Group Limited
- Other trademarks in Class 042
- Similar marks named CONNECT COLLABORATE ACCELERATE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 24, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 21, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 27, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 27, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 24, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 24, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 8, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 8, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 19, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 5, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 31, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 9, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 1, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 11, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 11, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 20, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 18, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 17, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 16, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 14, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 12, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |